Resistin overexpression impaired glucose tolerance in hepatocytes

European Cytokine Network

Volumn 17, Issue 3, 2006, Pages 189-195

  Zhou, Lei ^a   Li, Yixing ^a   Xia, Tao ^a   Feng, Shengqiu ^a   Chen, Xiaodong ^a   Yang, Zaiqing ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Glucose tolerance; Insulin resistance; Resistin; Rosiglitazone

Indexed keywords

CYTOPLASMIC LINKER PROTEIN 170; INSULIN; MICROTUBULE ASSOCIATED PROTEIN; PRIMER DNA; TUMOR PROTEIN;

ADULT; ARTICLE; CELL LINE; GENETIC TRANSFECTION; GENETICS; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ADULT; CELL LINE; DNA PRIMERS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33847674639     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19: 4046.
2. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252.
3. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307.
4. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502.
5. Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195.
6. Lin SY, Sheu WH, Chen WY, et al. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha. Mol Cell Endocrinol 2005; 232: 1.
7. Muse ED, Obici S, Bhanot S, et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232.
8. Taniguchi CM, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 2005; 115: 718.
9. Sambrook J, Russell DW. Molecular cloning: A laboratory manual. 3rd ed: Cold Spring Harbor Laboratory Press, 2001; (32-6, 48-50).
10. Yeh HJ, Chu TH, Shen TW. Ultrastructure of continuously cultured adult human liver cell. Acta Biologiac Experimentalis Sinica 1980; 13: 361.
11. Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248.
12. Fernandez-Mejia C, Vega-Allende J, Rojas-Ochoa A, et al. Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression. Endocrinology 2001; 142: 1448.
13. Kim KH, Zhao L, Moon Y, et al. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 2004; 101: 6780.
14. Kitagawa Y, Bujo H, Takahashi K, et al. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia 2004; 47: 1847.
15. Song H, Shojima N, Sakoda H, et al. Resistin is regulated by C/ EBPs, PPARs, and signal-transducing molecules. Biochem Biophys Res Commun 2002; 299: 291.
16. Zhou L, Xia T, Li Y, et al. Transcriptional regulation of the resistin gene. Domest Anim Endocrinol 2006; 30: 98.
17. Shojima N, Sakoda H, Ogihara T, et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002; 51: 1737.
18. Degawa-Yamauchi M, Bovenkerk JE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88: 5452.
19. Steppan CM, Wang J, Whiteman EL, et al. Activation of SOCS-3 by resistin. Mol Cell Biol 2005; 25: 1569.
20. Seo JB, Noh MJ, Yoo EJ, et al. Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Mol Endocrinol 2003; 17: 1522.
21. Ide T, Shimano H, Yahagi N, et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 2004; 6: 351.